Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
483.75
455.05
438.06
397.85
369.54
344.61
308.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
483.75
455.05
438.06
397.85
369.54
344.61
308.02
Raw Material Cost
165.85
160.01
149.24
143.03
114.84
98.42
106.05
Purchase of Finished goods
62.58
53.80
65.91
58.60
65.29
65.21
45.81
(Increase) / Decrease In Stocks
-6.34
-2.63
-10.39
-8.73
-6.99
9.07
-4.06
Employee Cost
92.73
84.84
77.85
69.65
49.88
40.34
44.91
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
96.10
84.26
73.92
62.74
68.47
59.63
58.40
Total Expenditure (Excl Depreciation)
410.92
380.27
356.53
325.29
291.50
272.67
251.11
Operating Profit (PBDIT) excl Other Income
72.83
74.78
81.53
72.56
78.04
71.94
56.91
Other Income
37.65
29.36
27.41
18.58
8.11
3.13
6.85
Operating Profit (PBDIT)
110.48
104.14
108.94
91.14
86.15
75.07
63.76
Interest
0.74
1.52
0.96
0.88
0.89
0.99
2.58
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
109.74
102.62
107.98
90.26
85.26
74.08
61.18
Depreciation
10.82
9.67
7.94
6.75
6.09
5.67
5.50
Profit Before Tax
98.92
92.94
100.03
83.50
79.17
68.40
55.70
Tax
22.66
22.17
25.32
23.16
20.84
18.74
13.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
76.26
70.77
74.71
60.33
58.33
49.66
42.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
76.26
70.77
74.71
60.33
58.33
49.66
42.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.01
-0.01
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
76.26
70.77
74.71
60.33
58.32
49.65
42.49
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
14.28
10.37
14.0
10.79
8.79
6.73
5.46
Operating Profit Margin (Excl OI)
15.06%
16.43%
18.61%
18.24%
21.12%
20.88%
18.48%
Gross Profit Margin
22.69%
22.55%
24.65%
22.69%
23.07%
21.5%
19.86%
PAT Margin
15.76%
15.55%
17.05%
15.16%
15.78%
14.41%
13.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 6.31% vs 3.88% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 7.76% vs -5.27% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is -2.61% vs -8.28% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -51.32% vs 58.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
Compare Nine Monthly Results Of Lincoln Pharma. With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
483.75
0
483.75
Other Operating Income
0.00
0.00
0.00
Total Operating income
483.75
0
483.75
Raw Material Cost
165.85
0
165.85
Purchase of Finished goods
62.58
0
62.58
(Increase) / Decrease In Stocks
-6.34
0
-6.34
Employee Cost
92.73
0
92.73
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
96.10
0.00
96.10
Total Expenditure (Excl Depreciation)
410.92
0
410.92
Operating Profit (PBDIT) excl Other Income
72.83
0.00
72.83
Other Income
37.65
0
37.65
Operating Profit (PBDIT)
110.48
0
110.48
Interest
0.74
0
0.74
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
109.74
0
109.74
Depreciation
10.82
0
10.82
Profit Before Tax
98.92
0
98.92
Tax
22.66
0
22.66
Provisions and contingencies
0.00
0
0.00
Profit After Tax
76.26
0
76.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
76.26
0
76.26
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
76.26
0
76.26
Equity Capital
20.03
0
20.03
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
22.69%
0%
0.00
22.69%
PAT Margin
15.76%
0%
0.00
15.76%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 483.75 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 6.31% vs 3.88% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 76.26 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 7.76% vs -5.27% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 72.83 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -2.61% vs -8.28% in Dec 2024
Nine Monthly - Interest
Interest 0.74 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -51.32% vs 58.33% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.06%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
